CHC Healthcare Group
TWSE:4164.TW
41.6 (TWD) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) TWD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3,877.137 | 2,974.352 | 2,439.564 | 2,554.911 | 2,950.052 | 2,507.466 | 2,117.116 | 2,205.206 | 2,395.331 | 2,091.026 | 2,062.991 | 1,989.67 | 1,995.368 | 1,867.51 | 170.398 |
| Cost of Revenue
| 2,808.977 | 2,072.038 | 1,590.083 | 1,724.201 | 2,144.05 | 1,776.68 | 1,428.463 | 1,585.595 | 1,635.602 | 1,484.277 | 1,424.042 | 1,155.846 | 1,072.096 | 989.143 | 129.473 |
| Gross Profit
| 1,068.16 | 902.314 | 849.481 | 830.71 | 806.002 | 730.786 | 688.653 | 619.611 | 759.729 | 606.749 | 638.949 | 833.824 | 923.272 | 878.367 | 40.925 |
| Gross Profit Ratio
| 0.276 | 0.303 | 0.348 | 0.325 | 0.273 | 0.291 | 0.325 | 0.281 | 0.317 | 0.29 | 0.31 | 0.419 | 0.463 | 0.47 | 0.24 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 6.252 | 4.874 | 1.193 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 235.983 | 238.348 | 233.558 | 191.688 | 166.584 | 192.217 | 222.005 | 174.004 | 253.104 | 137.901 | 131.463 | 163.623 | 94.133 | 69.621 | 8.109 |
| Selling & Marketing Expenses
| 218.424 | 184.049 | 122.279 | 118.774 | 124.041 | 124.613 | 113.773 | 137.452 | 136.711 | 95.402 | 111.162 | 99.763 | 89.271 | 202.36 | 20.662 |
| SG&A
| 454.407 | 422.397 | 355.837 | 310.462 | 290.625 | 316.83 | 335.778 | 311.456 | 389.815 | 233.303 | 242.625 | 263.386 | 183.404 | 271.981 | 28.771 |
| Other Expenses
| 12.668 | 67.146 | 42.052 | 17.325 | 26.999 | -5.219 | -299.75 | -9.581 | -20.529 | -8.141 | 0.716 | -28.453 | 1.646 | 3.166 | -0.687 |
| Operating Expenses
| 454.407 | 422.397 | 355.837 | 316.714 | 295.499 | 318.023 | 335.778 | 311.456 | 389.815 | 233.303 | 242.625 | 263.386 | 183.404 | 271.981 | 28.771 |
| Operating Income
| 648.708 | 559.259 | 553.901 | 543.094 | 535.869 | 412.763 | 352.875 | 308.155 | 369.914 | 373.446 | 396.324 | 570.438 | 739.868 | 606.386 | 12.154 |
| Operating Income Ratio
| 0.167 | 0.188 | 0.227 | 0.213 | 0.182 | 0.165 | 0.167 | 0.14 | 0.154 | 0.179 | 0.192 | 0.287 | 0.371 | 0.325 | 0.071 |
| Total Other Income Expenses Net
| -89.278 | -75.424 | -62.832 | -79.098 | -59.276 | -44.594 | -378.951 | -80.421 | -87.046 | -49.038 | -18.838 | -27.845 | -23.468 | 6.203 | -1.375 |
| Income Before Tax
| 559.43 | 483.835 | 491.069 | 463.996 | 476.593 | 368.169 | -26.076 | 227.734 | 282.868 | 324.408 | 377.486 | 542.593 | 716.4 | 612.589 | 10.779 |
| Income Before Tax Ratio
| 0.144 | 0.163 | 0.201 | 0.182 | 0.162 | 0.147 | -0.012 | 0.103 | 0.118 | 0.155 | 0.183 | 0.273 | 0.359 | 0.328 | 0.063 |
| Income Tax Expense
| 134.192 | 95.185 | 110.787 | 101.084 | 86.162 | 50.34 | 63.21 | 67.13 | 60.181 | 60.615 | 85.815 | 112.199 | 130.689 | 121.525 | 4.23 |
| Net Income
| 418.866 | 356.571 | 381.633 | 366.389 | 395.172 | 323.422 | -86.695 | 158.932 | 226.518 | 265.766 | 296.862 | 430.685 | 583.45 | 483.548 | 6.299 |
| Net Income Ratio
| 0.108 | 0.12 | 0.156 | 0.143 | 0.134 | 0.129 | -0.041 | 0.072 | 0.095 | 0.127 | 0.144 | 0.216 | 0.292 | 0.259 | 0.037 |
| EPS
| 2.55 | 2.21 | 2.43 | 2.53 | 2.83 | 1.86 | -0.62 | 1.14 | 1.73 | 2.04 | 2.41 | 3.89 | 5.39 | 4.94 | 0.099 |
| EPS Diluted
| 2.26 | 1.98 | 2.18 | 1.95 | 2.46 | 1.86 | -0.62 | 1.13 | 1.54 | 2.03 | 2.37 | 3.87 | 5.39 | 4.94 | 0.099 |
| EBITDA
| 1,243.171 | 1,058.641 | 1,014.493 | 983.443 | 947.621 | 831.615 | 477.678 | 693.809 | 738.615 | 718.634 | 735.672 | 853.79 | 931.393 | 783.577 | 20.116 |
| EBITDA Ratio
| 0.321 | 0.356 | 0.416 | 0.385 | 0.321 | 0.332 | 0.226 | 0.315 | 0.308 | 0.344 | 0.357 | 0.429 | 0.467 | 0.42 | 0.118 |